Research reviewed by Gram shows that the rules used to define metabolic syndrome strongly affect how many people are diagnosed with it. In nine studies, Finnish adults were labeled as having the condition at rates from 17.7% to 43.0%, depending on which criteria were applied. Waist size cutoffs were the factor most often linked to disagreement.
A new systematic review published in Frontiers in Endocrinology in 2026 looks at why the number of people diagnosed with metabolic syndrome changes so much depending on which rules are used. Metabolic syndrome is a group of risk signs, including a large waist, high blood pressure, high blood sugar, high triglycerides, and low HDL cholesterol. The researchers reviewed nine studies that applied different sets of diagnostic rules to the same groups of adults. Gram Research analysis of these studies found that the share of Finnish adults labeled as having the condition ranged from 17.7% to 43.0%, depending on the criteria used. The findings suggest that waist size cutoffs matter a great deal, so rates from different studies may not be directly comparable.
Key Statistics
A 2026 systematic review of nine studies found that the share of Finnish adults classified as having metabolic syndrome ranged from 17.7% to 43.0%, depending on which diagnostic criteria were used.
A 2026 systematic review found that a nationwide Iranian study estimated metabolic syndrome prevalence at 32.0% using IDF criteria and 47.6% using JIS criteria.
A 2026 systematic review reported that IDF and JIS criteria agreed closely in Finnish adults, with a kappa score of 0.97 on a scale where 1.0 means perfect agreement.
The Quick Take
- What they studied: Researchers wanted to know how different definitions of metabolic syndrome change the number of people diagnosed with it, how well the definitions agree with each other, and whether waist size cutoffs should differ by ethnic group.
- Who participated: The review combined nine published studies of adults. The studies came from different countries, with a nationwide study in Iran and studies of adults in Finland among them. The review did not report a single combined number of participants.
- Key finding: The same group of people was labeled as having metabolic syndrome at very different rates depending on the rules used. In Finnish adults, rates ranged from 17.7% using WHO criteria to 43.0% using JIS criteria. Waist size was the factor most often linked to disagreement between rule sets.
- What it means for you: Your metabolic syndrome status can depend on which set of rules a doctor or study uses, so ask your clinician which criteria apply to you. Your waist measurement and blood test results still matter for your health, whatever label is used.
The Research Details
A systematic review is a careful way of gathering and reviewing all the studies that answer a specific question. The authors followed a set of standard reporting steps called PRISMA 2020, which help make the process clear and repeatable. To be included, a study had to compare two or more definitions of metabolic syndrome in the same group of adults.
From each study, the authors recorded details such as the diagnostic rules used, the cutoff numbers for each risk sign, how many people were classified as having the condition, and how often two rule sets agreed or disagreed. They also noted whether any study adjusted waist cutoffs for a particular region or ethnic group.
Because the studies differed a lot in who they tested and how they defined the condition, the authors could not combine the numbers into one statistical estimate. Instead, they described and compared the findings side by side. This is called a descriptive synthesis.
Metabolic syndrome is often used to flag people at higher risk of heart disease and type 2 diabetes, so the way it is defined affects who gets flagged for follow-up care. A review that looks across many studies can show whether the differences come from the people studied or from the rules used. In this case, the review shows that the rules themselves play a large role. This helps explain why published numbers can look so different from one another.
Systematic reviews are considered one of the stronger ways to summarize research because they follow a clear, published method and search for all relevant studies. This review followed the PRISMA 2020 guidelines, which is a good sign of careful reporting. However, the total number of participants was not reported, and the included studies varied widely, so the findings are best read as a broad picture rather than a precise measurement. The authors themselves describe the results as descriptive.
What the Results Show
The most striking result is how much the rate of metabolic syndrome changed when the same population was assessed using different criteria. Among Finnish adults, the rate ranged from 17.7% using WHO criteria to 43.0% using JIS criteria. That means a large share of people could be labeled as having the condition or not, depending only on which rules were applied.
A similar pattern appeared in a nationwide Iranian study. Rates ranged from 32.0% using IDF criteria to 47.6% using JIS criteria. These gaps show that prevalence numbers from one framework may not translate directly into another.
The review also found that some definitions agree closely with each other. For example, IDF and JIS criteria matched very well in the Finnish data, with a kappa score of 0.97. A kappa score of 1.0 would mean perfect agreement, so this indicates that the two systems tend to classify people in almost the same way. Comparisons involving WHO criteria showed lower agreement, which suggests the WHO framework sorts people differently from the others.
Waist circumference was the factor most often linked to disagreement between diagnostic systems. When researchers adjusted waist cutoffs for region or ethnicity, the overall rate of metabolic syndrome changed significantly. This suggests that a single waist number may not fit every group equally well.
Several other points stood out. Because the rules differ, a person might be labeled as having metabolic syndrome under one framework and not under another, even when their health measurements are identical. This can affect whether someone is offered lifestyle advice, screening, or follow-up testing.
The authors also highlighted that waist thresholds may vary by ethnicity, which means a waist size that signals risk in one group may not carry the same meaning in another. This is an important consideration for clinicians and researchers working with diverse populations.
Finally, the review points out that the clinical value of many alternative definitions has not been fully tested. Few studies checked whether a given definition predicts real health outcomes, such as heart attacks or diabetes, better than another.
Researchers have long known that metabolic syndrome has no single universal definition. Major groups such as the World Health Organization, the International Diabetes Federation, and the Joint Interim Statement have each proposed their own versions. This review pulls together the head-to-head comparisons and shows how much those versions can change the results. It supports the idea that the same term can describe different groups of people depending on the rules used.
The biggest limitation is that the nine studies were quite different from one another. They tested different populations, used different cutoffs, and reported their results in different ways. Because of this, the authors could not combine the data into one overall estimate. The review also did not report the total number of participants, which makes it harder to judge how much weight the findings should carry.
Another limitation is that the review focused on how the definitions compare with each other, not on whether they predict actual health outcomes. The authors note that more research is needed to test which definitions best match real-world results such as heart disease or diabetes.
Finally, the review included a limited number of studies, and some regions were represented more than others. Results from Finland and Iran may not apply to every country or ethnic group.
The Bottom Line
Research shows that the diagnostic rules used for metabolic syndrome can change how many people are classified as having it, so the label should be interpreted with care. Confidence is high that prevalence depends strongly on the definition used, based on consistent differences across the reviewed studies. Confidence is moderate that waist cutoffs should be adjusted for ethnicity, since the review points to this but the evidence base is still limited. Confidence is low for any claim about which definition best predicts health outcomes, because few studies have tested this directly.
Doctors, public health workers, researchers, and anyone comparing metabolic syndrome statistics across studies should pay close attention to these findings. People who have been told they have or do not have metabolic syndrome may also benefit from asking which criteria were used. People who have never been screened for risk factors such as high blood pressure, blood sugar, or waist size can use the findings as a reminder to talk with a clinician. This review is not a treatment guide, so it should not be used to make changes to medication.
This review is a snapshot of how definitions compare, not a study of health changes over time, so it does not offer a timeline for benefits. Changes in waist size, blood pressure, blood sugar, and cholesterol often take weeks to months of consistent effort to show up on lab tests. Any changes in diagnosis labels would depend on how a clinician applies the criteria at a checkup.
Frequently Asked Questions
What is metabolic syndrome and why do experts disagree on how to diagnose it?
Metabolic syndrome is a cluster of risk signs, including a large waist, high blood pressure, high blood sugar, and unhealthy blood fats. Experts use different sets of cutoff numbers, so the same person can be counted as having it under one system but not another. A 2026 review found this changes prevalence substantially.
How much does waist size affect who gets diagnosed with metabolic syndrome?
Waist size was the factor most often linked to disagreement between diagnostic systems. A 2026 review found that adjusting waist cutoffs for region or ethnicity significantly changed how many people were classified. Waist thresholds may need to vary by ethnic group to classify people accurately.
Can I compare metabolic syndrome rates from two different studies?
Often not directly. A 2026 systematic review of nine studies concluded that prevalence depends heavily on the definition used, so rates from studies using different criteria may not be comparable. Check which diagnostic framework each study used before comparing results.
What should I do if I have some signs of metabolic syndrome?
Talk with a doctor about your blood pressure, blood sugar, cholesterol, and waist measurement. This review did not test treatments, so it cannot say which steps prevent problems. Regular checkups and healthy eating and activity habits remain the usual starting point for most people.
Want to Apply This Research?
- Track your waist circumference once a week, measured at the same point, such as just above the hip bone, in the morning before eating. Also log your blood pressure and fasting blood sugar or cholesterol results each time you get them from a clinician. Record which diagnostic criteria your doctor used, if they tell you, so you can compare results over time.
- Set a weekly reminder to measure your waist and log it in the app. Use the app to note one small habit each week, such as a 10-minute walk after dinner or swapping sugary drinks for water. Review your waist trend with your clinician rather than focusing on a single diagnostic label.
- Build a long-term record that includes waist size, blood pressure, blood sugar, cholesterol, and any diagnostic labels from your care team. Review trends every three months, and bring the app data to yearly checkups. Because cutoffs differ by framework and ethnicity, ask your clinician which standard is being used before interpreting changes.
This article summarizes a systematic review of research on how diagnostic definitions of metabolic syndrome differ. It is for general education only and is not medical advice. Metabolic syndrome diagnosis and risk should be discussed with a qualified healthcare provider, who can interpret your measurements using the criteria appropriate for you.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.